Literature DB >> 23143236

Room-temperature X-ray diffraction studies of cisplatin and carboplatin binding to His15 of HEWL after prolonged chemical exposure.

Simon W M Tanley1, Antoine M M Schreurs, Loes M J Kroon-Batenburg, John R Helliwell.   

Abstract

The anticancer complexes cisplatin and carboplatin are known to bind to both the Nδ and the Nℇ atoms of His15 of hen egg-white lysozyme (HEWL) in the presence of dimethyl sulfoxide (DMSO). However, neither binds in aqueous media after 4 d of crystallization and crystal growth, suggesting that DMSO facilitates cisplatin/carboplatin binding to the N atoms of His15 by an unknown mechanism. Crystals of HEWL cocrystallized with cisplatin in both aqueous and DMSO media, of HEWL cocrystallized with carboplatin in DMSO medium and of HEWL cocrystallized with cisplatin and N-acetylglucosamine (NAG) in DMSO medium were stored for between seven and 15 months. X-ray diffraction studies of these crystals were carried out on a Bruker APEX II home-source diffractometer at room temperature. Room-temperature X-ray diffraction data collection removed the need for cryoprotectants to be used, ruling out any effect that the cryoprotectants might have had on binding to the protein. Both cisplatin and carboplatin still bind to both the Nδ and Nℇ atoms of His15 in DMSO media as expected, but more detail for the cyclobutanedicarboxylate (CBDC) moiety of carboplatin was observed at the Nℇ binding site. However, two molecules of cisplatin were now observed to be bound to His15 in aqueous conditions. The platinum peak positions were identified using anomalous difference electron-density maps as a cross-check with Fo-Fc OMIT electron-density maps. The occupancies of each binding site were calculated using SHELXTL. These results show that over time cisplatin binds to both N atoms of His15 of HEWL in aqueous media, whereas this binding is speeded up in the presence of DMSO. The implication of cisplatin binding to proteins after a prolonged period of time is an important consideration for the length of treatment in patients who are given cisplatin.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23143236      PMCID: PMC3515368          DOI: 10.1107/S1744309112042005

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  23 in total

1.  Cisplatin interaction with amino acids cysteine and methionine from gas phase to solutions with constant pH.

Authors:  Tomás Zimmermann; Jaroslav V Burda
Journal:  Interdiscip Sci       Date:  2010-01-28       Impact factor: 2.233

2.  Radiation-induced site-specific damage of mercury derivatives: phasing and implications.

Authors:  Udupi A Ramagopal; Zbigniew Dauter; Radhakannan Thirumuruhan; Elena Fedorov; Steven C Almo
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-08-16

Review 3.  Biophysical characterisation of adducts formed between anticancer metallodrugs and selected proteins: new insights from X-ray diffraction and mass spectrometry studies.

Authors:  Angela Casini; Annalisa Guerri; Chiara Gabbiani; Luigi Messori
Journal:  J Inorg Biochem       Date:  2008-01-08       Impact factor: 4.155

4.  The interdependence of wavelength, redundancy and dose in sulfur SAD experiments.

Authors:  Michele Cianci; John R Helliwell; Atsuo Suzuki
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2008-11-18

5.  Covalent binding of cisplatin impairs the function of Na(+)/K(+)-ATPase by binding to its cytoplasmic part.

Authors:  Miroslav Huličiak; Jan Vacek; Marek Sebela; Eva Orolinová; Joanna Znaleziona; Marika Havlíková; Martin Kubala
Journal:  Biochem Pharmacol       Date:  2012-02-27       Impact factor: 5.858

6.  The stability of carboplatin in ambulatory continuous infusion regimes.

Authors:  G J Sewell; C M Riley; C G Rowland
Journal:  J Clin Pharm Ther       Date:  1987-12       Impact factor: 2.512

7.  Structural studies of the effect that dimethyl sulfoxide (DMSO) has on cisplatin and carboplatin binding to histidine in a protein.

Authors:  Simon W M Tanley; Antoine M M Schreurs; Loes M J Kroon-Batenburg; Joanne Meredith; Richard Prendergast; Danielle Walsh; Patrick Bryant; Colin Levy; John R Helliwell
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2012-04-17

8.  Insights into the molecular mechanisms of protein platination from a case study: the reaction of anticancer platinum(II) iminoethers with horse heart cytochrome c.

Authors:  Angela Casini; Chiara Gabbiani; Guido Mastrobuoni; Raffaella Zoe Pellicani; Francesco Paolo Intini; Fabio Arnesano; Giovanni Natile; Gloriano Moneti; Simona Francese; Luigi Messori
Journal:  Biochemistry       Date:  2007-10-09       Impact factor: 3.162

9.  Presenting your structures: the CCP4mg molecular-graphics software.

Authors:  S McNicholas; E Potterton; K S Wilson; M E M Noble
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  9 in total

1.  Crystallography and chemistry should always go together: a cautionary tale of protein complexes with cisplatin and carboplatin.

Authors:  Ivan Shabalin; Zbigniew Dauter; Mariusz Jaskolski; Wladek Minor; Alexander Wlodawer
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2015-08-28

2.  Effect of temperature on the interaction of cisplatin with the model protein hen egg white lysozyme.

Authors:  Giarita Ferraro; Andrea Pica; Irene Russo Krauss; Francesca Pane; Angela Amoresano; Antonello Merlino
Journal:  J Biol Inorg Chem       Date:  2016-04-04       Impact factor: 3.358

Review 3.  Safeguarding Structural Data Repositories against Bad Apples.

Authors:  Wladek Minor; Zbigniew Dauter; John R Helliwell; Mariusz Jaskolski; Alexander Wlodawer
Journal:  Structure       Date:  2016-02-02       Impact factor: 5.006

4.  Experiences with archived raw diffraction images data: capturing cisplatin after chemical conversion of carboplatin in high salt conditions for a protein crystal.

Authors:  Simon W M Tanley; Kay Diederichs; Loes M J Kroon-Batenburg; Antoine M M Schreurs; John R Helliwell
Journal:  J Synchrotron Radiat       Date:  2013-10-01       Impact factor: 2.616

5.  Sharing Big Data.

Authors:  Marek Grabowski; Wladek Minor
Journal:  IUCrJ       Date:  2017-01-01       Impact factor: 4.769

6.  Experiences with making diffraction image data available: what metadata do we need to archive?

Authors:  Loes M J Kroon-Batenburg; John R Helliwell
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2014-09-30

7.  Carboplatin binding to histidine.

Authors:  Simon W M Tanley; Kay Diederichs; Loes M J Kroon-Batenburg; Colin Levy; Antoine M M Schreurs; John R Helliwell
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-08-29       Impact factor: 1.056

8.  Re-refinement of 4g4a: room-temperature X-ray diffraction study of cisplatin and its binding to His15 of HEWL after 14 months chemical exposure in the presence of DMSO.

Authors:  Simon W M Tanley; Antoine M M Schreurs; Loes M J Kroon-Batenburg; John R Helliwell
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2016-02-19       Impact factor: 1.056

9.  Structural dynamics of cisplatin binding to histidine in a protein.

Authors:  Simon W M Tanley; John R Helliwell
Journal:  Struct Dyn       Date:  2014-06-17       Impact factor: 2.920

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.